Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

KRMD

+ Watchlist+ Portfolio

KORU Medical Systems, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$3.49
52-Week Range
$2.86 – $6.61
Market Cap
$149.64M
P/E (TTM)
—
EPS (TTM)
-0.02
Dividend Yield
0.00%
Advanced Metrics
Price/Book
8.25
PEG Ratio
—
Return on Equity
-4.59%
Return on Assets
-1.29%
Gross Margin
63.63%
Operating Margin
-1.24%
Profit Margin
-1.78%
Current Ratio
2.96
Debt/Equity
0.18
Total Debt
$3.50M
Free Cash Flow
$-1.05M
Revenue Growth
11.20%
Earnings Growth
—
Enterprise Value
$145.78M

Market Snapshot

About

KORU Medical Systems develops and commercializes innovative and patient-centric subcutaneous drug delivery systems. The company's flagship product, the Freedom System, is a wearable infusion pump that enables patients to self-administer immunoglobulin therapy at home. KORU's technology improves patient quality of life by providing convenient alternatives to hospital-based infusion treatments.